ALK and inflammatory myofibroblastic tumor: ALK acquires an oncogenic potential following gene fusion, as in anaplastic large cell lymphoma, lung cancer and IMT, or as a result of a missense mutation, as in neuroblastoma and anaplastic thyroid cancer.[6]